Source 1review2021Signal Transduction and Targeted Therapy
Toolkit/CD39
CD39
Taxonomy: Mechanism Branch / Component. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Additional high-signal leads cluster into four enrichment themes explicitly aligned to that scope... ectonucleotidase control via CD39 and CD73.
Usefulness & Problems
No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Component: A low-level protein part used inside a larger architecture that realizes a mechanism.
Mechanisms
control of adenosine-generating pathwaysectonucleotidase-mediated extracellular nucleotide metabolismregulation of extracellular purinergic signallingTechniques
Selection / EnrichmentTarget processes
selectionInput: Chemical
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
CD39 and CD73 are presented as ectonucleotidase regulators of extracellular purinergic signalling and adenosine-generating pathways.
PANX1 and VNUT are presented as ATP-release or transmission components within the purinergic signalling framework covered by the review.
This review synthesizes purinergic signalling around ATP and adenosine ligands, P1/P2X/P2Y receptor families, ATP-release components including PANX1 and VNUT, and ectonucleotidase control via CD39 and CD73.
Approval Evidence
1 source2 linked approval claimsfirst-pass slug cd39
Additional high-signal leads cluster into four enrichment themes explicitly aligned to that scope... ectonucleotidase control via CD39 and CD73.
Source:
mechanistic summarysupports
CD39 and CD73 are presented as ectonucleotidase regulators of extracellular purinergic signalling and adenosine-generating pathways.
Source:
review scope summarysupports
This review synthesizes purinergic signalling around ATP and adenosine ligands, P1/P2X/P2Y receptor families, ATP-release components including PANX1 and VNUT, and ectonucleotidase control via CD39 and CD73.
Source:
Comparisons
No literature-backed comparison notes have been materialized for this record yet.
Ranked Citations
- 1.